dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Fernandez-Fernandez, Beatriz |
dc.contributor.author | Fernandez-Prado, Raul |
dc.contributor.author | Martínez-Castelao, Alberto |
dc.contributor.author | Navarro-González, Juan F |
dc.contributor.author | Porrini, Esteban |
dc.contributor.author | Soler Romeo, Maria Jose |
dc.contributor.author | Gorriz, Jose Luis |
dc.date.accessioned | 2019-08-05T07:08:43Z |
dc.date.available | 2019-08-05T07:08:43Z |
dc.date.issued | 2019-05-31 |
dc.identifier.citation | Fernandez-Fernandez B, Fernandez-Prado R, Górriz JL, Martinez-Castelao A, Navarro-González JF, Porrini E, et al. Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan? Clin Kidney J. 2019;12(3):313–21. |
dc.identifier.issn | 2048-8505 |
dc.identifier.uri | https://hdl.handle.net/11351/4234 |
dc.description | Albuminúria; Atrasentan; Canagliflozina |
dc.description.sponsorship | Funded by FIS/Fondos FEDER (PI16/02057, PI16/01814. PI17/00257, ISCIII-RETIC REDinREN RD016/0009), Sociedad Espanola de Nefrología, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM. E.P. is a researcher in the Ramón y Cajal Program. |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartofseries | Clinical Kidney Journal;12(3) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Glucòsids - Ús terapèutic |
dc.subject | Pirrolidina - Ús terapèutic |
dc.subject | Nefropaties diabètiques - Tractament |
dc.subject.mesh | Diabetic Nephropathies |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Canagliflozin |
dc.subject.mesh | Atrasentan |
dc.subject.mesh | /therapeutic use |
dc.title | Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan? |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1093/ckj/sfz070 |
dc.subject.decs | nefropatías diabéticas |
dc.subject.decs | /tratamiento farmacológico |
dc.subject.decs | canagliflozina |
dc.subject.decs | atrasentán |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://academic.oup.com/ckj/article/12/3/313/5509503 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Fernandez-Fernandez B, Fernandez-Prado R] IIS-Fundacion Jimenez Diaz Madrid, Spain. Universidad Autónoma de Madrid, Madrid, Spain. REDINREN, Madrid, Spain. Grupo Español de Estudio de la Nefropatía Diabética, Barcelona, Spain. [Górriz JL] Grupo Español de Estudio de la Nefropatía Diabética, Barcelona, Spain. Hospital Clínico Universitario, Universitat de Valencia-INCLIVA, Valencia, Spain. [Martinez-Castelao A] Grupo Español de Estudio de la Nefropatía Diabética, Barcelona, Spain. Hospital Universitari de Bellvitge, Hospitalet, Barcelona, Spain. [Navarro-González JF] Grupo Español de Estudio de la Nefropatía Diabética, Barcelona, Spain. Unidad de Investigación y Servicio de Nefrología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain. [Porrini E] Grupo Español de Estudio de la Nefropatía Diabética, Barcelona, Spain. Instituto de Tecnologías Biomédicas, Hospital Universitario de Canarias, Universidad de La Laguna, Santa Cruz de Tenerife, Spain. [Soler MJ] Grupo Español de Estudio de la Nefropatía Diabética, Barcelona, Spain. Servei de Nefrologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. |
dc.identifier.pmid | 31198532 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |